Age, body composition, and insulin resistance further modify your responseolder adults or those with significant insulin resistance may titrate more slowly to higher maintenance doses
When inflammation is controlled, mobility and flexibility improve, reducing strain on the back
That changed at the end of 2025, when the FDA approved the Wegovy pill (oral semaglutide 25 mg), making it the first and only oral GLP-1 medication approved for chronic weight management in adults
By recognizing and reporting this side effect, patients can work with their healthcare providers to find ways to manage it and continue their treatment effectively
However, the lack of control group limits the strength of these findings to some extent
Recuperato da: Cooper J, Donovan K, Michel H, Peterson L, Todd-Thompson M, Gillette C, et al